AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 68(2), 2003, pp. 235-241
Copyright © 2003 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FERRER, J. F.
Right arrow Articles by GALLIGAN, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FERRER, J. F.
Right arrow Articles by GALLIGAN, D.
Related Collections
Right arrow Trypanosomiasis
Right arrow Chagas Disease
Right arrow Epidemiology

ASSOCIATION AND EPIDEMIOLOGIC FEATURES OF TRYPANOSOMA CRUZI AND HUMAN T CELL LYMPHOTROPIC A VIRUS TYPE II IN INHABITANTS OF THE PARAGUAYAN GRAN CHACO

JORGE F. FERRER, EDUARDO ESTEBAN, ALICIA MURUA, SILVINA GUTIERREZ, SYAMALIMA DUBE, BERNARD POIESZ, LEONARDO FELDMAN, MIGUEL A. BASOMBRIO, AND DAVID GALLIGAN
New Bolton Center, University of Pennsylvania, Kennett Square, Pennsylvania; Departamento de Virología, Universidad Nacional del Centro de la Provincia de Buenos Aires, Tandil, Argentina; State University of New York Health Science Center, Syracuse, New York; Laboratorio de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Salta, Argentina


ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Serologic evidence of Trypanosoma cruzi infection was demonstrated in 43.5% of 519 Paleoamerindians and in only 2.5% of 161 non-Indians (Mennonites of German descent and Paraguayans of Spanish descent) inhabiting an area of western Paraguay that belongs to the Gran Chaco territory. These people ranged in age between two and 80 years. All were also tested for infection with the human T cell lymphotropic virus type II (HTLV-II). The prevalence of HTLV-II infection was 22.1% in Indians and 3.7% in non-Indians. As determined by a multivariate logistic regression analysis that controlled for relevant confounders, an HTLV-II-infected individual was 2.28 times more likely to be seropositive for T. cruzi than an HTLV-II negative. Possible explanations for this finding are discussed. The difference in T. cruzi prevalence between Indians and non-Indians was associated with differences between these groups in exposure to known risk factors for infection with the parasite. There were significant differences in the seroprevalence of T. cruzi among the two predominant Indian groups, even when they inhabited communities that were close to each other. These differences were associated with differences in the prevalence of HTLV-II infection but not with differences in exposure to known risk factors for T. cruzi infection. Infection with T. cruzi increased with age, was greater in males than in females, and clustered in families.


INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Trypanosoma cruzi, an hemoflagellate protozoan, is the causative agent of Chagas’ disease (American trypanosomasis), one of the most important endemic zoonotic diseases in Latin America. It has been estimated that T.cruzi infects 18 million people in the Americas, with the highest prevalence among those living in inadequate hygienic and housing conditions. Approximately 30% of the T. cruzi-infected individuals develop cardiopathy and/or megaesophagus/megacolon. The parasite is transmitted to humans mainly via the fecal droppings of hematophagous triatomine insects.1,2 Triatoma infestans is the triatomine species most commonly responsible for the transmission of T. cruzi in South America, including the Gran Chaco.3 In rare instances, the parasite is transmitted transplacentally or during partum, or by ingestion of contaminated and insufficiently cooked food. Transmission by blood transfusion may also occur and is probably responsible for the occurrence of T. cruzi infections in the United States.1,2,4,5

Non-human reservoirs of T. cruzi include dogs, cats, rats, mice, raccoons, opossums, and armadillos.1,2 The local pattern of transmission to humans depends mainly on the degree of contact with mammalian reservoirs and on the housing conditions. Thatched houses with cracked or unplastered walls and with a large number of residents, as well as the presence of dogs in bedroom areas, are associated with high risk of transmission of T. cruzi.6–8 Infected triatoma bugs inhabiting niches and cracks in walls and ceilings of such houses emerge at night to feed on the blood of sleeping humans by biting exposed skin areas.

We previously found a high seroprevalence of T. cruzi in Indian populations inhabiting areas of Paraguay and Argentina belonging to the Gran Chaco territory. (see dashed outline in map of South America in Figure 1Go).9 This is a vast, low, flat, and partially wooded tropical land with an area of approximately 900,000 km2. We have also shown that these populations are endemically infected with the human T cell lymphotropic virus type II (HTLV-II),10 which has been linked to rare neoplasms of the blood-forming organs and neurodegenerative diseases, and with hantavirus,11 the causative agent of an often fatal pulmonary syndrome. Evidence was reported indicating that in the Gran Chaco Indians transmission of HTLV-II occurs sexually and perinatally. None of these Indians were known to be intravenous drug users.10



View larger version (47K):
[in this window]
[in a new window]
 
    FIGURE 1. Map of South America showing the study area. The dashed line indicates the Gran Chaco.

 
Trypanosoma cruzi has been shown to cause immunosupression in acutely infected people and to inhibit T and B lymphocyte functions in vitro.12 The possibility that HTLV-II may cause immunologic impairment has been suggested by the observation of increased prevalence of other infections in HTLV-II-positive people.13–15 Thus, one of the main objectives of the present study was to examine the possible association between infections with T. cruzi and HTLV-II in people inhabiting the Paraguayan Chaco, where both agents are highly endemic. We were also interested in delineating further the main epidemiologic parameters of T. cruzi and HTLV infections in this population that is composed of people of different races and ethnic groups sharing the same environment, but differing in their lifestyles, cultural characteristics, and working conditions.


MATERIAL AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Study population. We examined 519 Paleoamerican Indians, 140 Mennonites of German descent, and 21 Paraguayans of Spanish descent inhabiting an area in the Gran Chaco (Figure 1Go) of approximately 1,000 km2 in the Department of Boqueron in western Paraguay. These people ranged in age from 2 to 80 years. Of the 680 people examined, 668 were 13–80 years old and 12 were 2–12 years old. All but three of the Indians examined belonged to the Chulupi, Lengua, Guarani, and Ayoreo groups, which represent different linguistic families. The study area included several Mennonite farming colonies, Indian communities, and a main town called Filadelfia. The Indians lived in communities containing varying numbers of families which, as a rule, belonged to a single ethnic group. These communities were situated in the immediate periphery of Filadelfia or in isolated rural sites. The dwellings in the Indian communities had roofs made of mud mixed with thatch and unplastered walls made of adobe or sun-dried mud and branches. In virtually all the Indian communities there was a relatively high concentration of dogs that ramble freely in and out of the dwellings, and the number of household residents was high. The Mennonites resided in Filadelfia, or in farms where they were engaged primarily in agricultural and cattle-raising activities. All but four of the Paraguayans examined lived in Filadelfia. In contrast to the Indian dwellings, the Mennonite and Paraguayan houses were well constructed with manufactured material, had plastered walls and roofs, and suitable sanitation facilities. Many of these houses also had screened windows and doors.

Many of the Indians living in the immediate periphery of Filadelfia worked in construction, factories, and other enterprises managed by Mennonites. Indians of both sexes often performed domestic tasks in Mennonite residences. The majority of the Mennonite and Indian men living in rural areas were involved in outdoor agricultural activities, clearing scrubs, planting and harvesting crops, gardening, and caring for livestock. Indian women also performed some of these tasks, but were primarily engaged in cleaning houses and outbuildings used for storage of food, grain, and hay, as well as in milking cows, harvesting, and gardening. The younger Mennonites living in Filadelfia worked in small factories, offices, and shops whereas most of the older Mennonites were retired farmers. The Paraguayan men worked in construction and in offices, and the women were involved in domestic activities

Study plan. The objectives of the study were explained to family heads and other members of the Indian communities through the community leaders or health delegates. The Director of the Hospital of Filadelfia and some of his associates also explained these objectives to members of the Mennonite associations and of Paraguayan groups. Participation was voluntary and based on accessibility. No special selection of the participants was made in terms of ethnicity, sex, age, location of the residence, occupation, or activity. Participants were assembled in local health centers, community-gathering buildings, or in the Hospital of Filadelfia. In addition to blood samples, demographic information was obtained from the participants. This information included age, sex, location, and setting (town, periphery of town, or rural) of the residence, occupation, and, in most cases, family relations. Information on the main risk factors for T. cruzi and HTLV-II infections was also obtained. This information included characteristics of the dwellings (whether they had unplastered walls with cracks, thatched roofs with crevices, and screened windows and doors), presence of dogs in the sleeping areas, and number of household residents. The people examined were also asked whether they observed triatomine bugs in their residences, whether they had been intravenous drug users, and whether they had received blood transfusions. The study also includes plasma samples, demographic information, and information on risk factors for T. cruzi and HTLV-II collected four and a half years earlier from 158 Indians inhabiting the study area.

The study plans and procedures were approved by the Institutional Review Committee (Committee of Studies on Human Beings) of the Office of Regulatory Affairs of the University of Pennsylvania. This is the formal body at the University of Pennsylvania that is responsible for ensuring that research on humans complies with U.S. government regulations on subject, safety, and ethical issues. The study plans and procedures, including those for informed consent, were also approved by the Paraguayan Ministerio de Salud Pública y Bienestar Social, which is the official regulatory institution for research involving humans in Paraguay.

Collection and processing of blood specimens. Heparinized and, in most cases, citrated blood samples were obtained by venipuncture from each individual. The blood samples were centrifuged at 1,500 x g for 20 minutes and the resulting plasma was stored at 4°C for several days and subsequently at -20°C. Peripheral blood leukocytes were obtained and preserved as described.10 Blood samples from children were obtained by fingerprick. Samples were processed within four hours after collection and were kept on ice until that time.

Testing for T.cruzi, HTLV, and hantavirus. As in our previous study,9 plasma samples were analyzed in the Chagas IgG enzyme-linked immunosorbent assay (ELISA) developed by Gull Laboratories (Salt Lake City, UT). The assay was conducted and the results were evaluated according to the manufacturers’ instructions. Comparative studies using a large number of positive and negative samples showed that the sensitivity and specificity of the Gull ELISA are comparable to those of the Chagas 2.0 enzyme immunoassay of Abbott Laboratories (Abbott Park, IL) and the consensus of the indirect immunohemagglutination assay and ELISA developed by Polychaco (Buenos Aires, Argentina).9 approximately 5% of the samples tested gave borderline results in the Gull ELISA. These samples were re-tested twice and scored as positive only if the optical densities were above the cutoff value in two of the tests. There were only five samples that remained indeterminate and were excluded from the study. The HTLV-I and HTLV-II testing was done using the differential Select HTLV ELISA kit (Biochem ImmunoSystems, Montreal, Quebec, Canada) and HTLV-I/II polymerase chain reaction assays. The performance of these assay and the criteria to evaluate the results have been reported.10 Plasma samples were tested for IgG antibodies to hantavirus by a highly sensitive and specific Western blot assay in which a recombinant N protein purified to homogeneity from the CC106 SN virus isolate was used as antigen. This assay was conducted and the results were evaluated as described.16

Statistical analysis. Multivariate logistic regression models, developed with the SAS Logistic program,17 were used to evaluate the associations of the dependent dichotomous variable antibody status to T. cruzi (positive/negative) and HTLV-II infection status (positive/negative) as a function of suggested risk factors for these agents. For reasons explained in the Results, the exposure risk factors for T. cruzi were considered collectively for each of the two main race groups (Indian and non-Indian). In another model, the ethnic group Chulupi was evaluated as a risk factor versus the other Indian groups. Confounders included in both models when examining T. cruzi status were age (continuous variable), sex (male/ female), HTLV-II infection status (positive/negative), and status of antibody to hantavirus (positive/negative). Hantavirus status was included as a confounder because a previous study11 showed that hantavirus seroprevalence in this population was very high. When examining for HTLV-II infection status, the same confounders were included except that the status of antibody to T. cruzi replaced HTLV-II infection status. The general form of the logistic model used was:


where: P(Y) = probability of an individual being positive for antibody to T. cruzi or HTLV-II infection, Bo = baseline odds, and Bn = risk factors and confounders described earlier.

The multivariate logistic regression approach allows for the evaluation of the results of antibody status to T. cruzi while controlling for age, sex, HTLV-II infection status, and status of antibody to hantavirus. Results for magnitude of effects are reported as odds ratios (ORs). Odds ratios are used to measure the intensity or degree of association between a risk factor and an outcome (e.g., status of antibody to T. cruzi). A ninety-five percent confidence interval (CI) was calculated for each OR. This interval indicates that the true parameter lies between the two end points 95% of the times.


RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
There was a clear-cut difference between the Indians and non-Indians (Mennonites and Paraguayans) examined with regard to exposure to risk factors for T. cruzi infection. This exposure was similar for all the Indians groups examined. Regardless of the ethnic group and their locations (rural or periphery of town), virtually all the Indians dwellings had roofs made of mud mixed with thatch and unplastered walls with many cracks and crevices that could serve as refuge for triatomine bugs. In contrast, the houses of the Mennonites and Paraguayans were well constructed with manufactured material, had plastered walls and roofs, suitable sanitary facilities and, in most cases, screened windows and doors. Unlike the houses of the non-Indians, in most of the Indians dwellings dogs rambled freely in and out of the sleeping areas. The number of residents was comparatively much greater in the Indian dwellings than in the houses of the non-Indians. Most of the Indians examined, but none of the Mennonites or Paraguayans, reported often seeing triatomine bugs in their dwellings. Thus, while all Indians were exposed to the known main risk factors for T. cruzi, the non-Indians were not exposed or were minimally exposed to these factors. Accordingly, in the statistical analysis of the T. cruzi seroprevalence data, the risk factors for this agent were considered collectively for each main race group (Indian versus non-Indian).

As shown in Table 1Go, antibodies to T. cruzi were detected in 43.5% of the 519 Indians, in 2.8% of the 140 Mennonites, and in none of the 21 Paraguayan examined. After adjusting for age, sex, HTLV-II status, and hantavirus status, the OR for race (Indians and non-Indians) was 33.82 (95% CI = 12.01–95.22). The prevalence of HTLV-II infection was 22.1% in Indians and 3.7% in the non-Indians (OR = 6.06, 95% CI = 2.49–14.75, after adjusting for age, sex, T. cruzi status, and hantavirus status). Both T. cruzi seroprevalence and prevalence of HTLV-II infection varied among the Indians groups. However, when compared with all the other Indians taken together, Chulupi had the greater prevalence of both T. cruzi (OR = 3.72, 95% CI = 2.50–5.55, after adjusting for age, sex, HTLV-II status, and hantavirus status) and HTLV-II (OR = 3.33, 95% CI = 2.01–5.52, after adjusting for age, sex, T. cruzi status, and hantavirus status). None of the subjects examined was positive for HTLV-I. No association was observed between HTLV-II infection and blood transfusion in the subjects examined and none of them reported intravenous drug use.


View this table:
[in this window]
[in a new window]
 
TABLE 1
Distribution of Trypanosoma cruzi and human T cell lymphotropic virus type II (HTLV-II) in people inhabiting western Paraguay
 
Of 121 individuals infected with HTLV-II, 71 (58.7%) were also positive for T. cruzi. In contrast, among the 559 HTLV-II negative individuals, only 159 (28.4%) were positive for T. cruzi. After adjusting for age, sex, race (Indians versus non-Indians), and hantavirus status, the OR of a person infected with HTLV-II of being positive for T. cruzi was 2.28 (95% CI = 1.45–3.60) times greater than that of an HTLV-II negative person. Upon a further analysis of the Indians, HTLV-II infection was found to be a significant risk factor (OR = 1.65, 95% CI = 1.01–2.68) for T. cruzi seropositivity after adjusting for age, sex, hantavirus status, and Chulupi ethnic group. The Chulupi ethnic group was included as a confounder in this analysis because it was most numerous and had the highest prevalence of antibodies to T. cruzi and HTLV-II infection.

The communities and residences of 658 of the 680 people listed in Table 1Go were located in five main zones, which we labeled A, B, C, D, and E (Figure 1Go) (22 people examined lived in other zones). These communities and residences were either in a rural setting, at the periphery of Filadelfia, or in Filadelfia. As shown in Table 2Go, antibodies to T. cruzi and HTLV-II infection were detected in people living in all these zones. Communities of Chulupi and Lengua, the two main Indian groups examined, coexisted in the immediate periphery of Filadelfia (Zone C) and in the rural zone of Yalve Sanga (Zone D). After adjusting for age, sex, HTLV-II status, and hantavirus status, in both zones the OR of a Chulupi individual of being seropositive for T. cruzi was 4.88 (95% CI = 1.84–12.93) and 2.50 (95% CI = 1.02–6.16) times greater than that of a Lengua individual, respectively. These differences in T. cruzi seroprevalence were paralleled by differences in the prevalence of HTLV-II infection.


View this table:
[in this window]
[in a new window]
 
TABLE 2
Distribution of Trypanosoma cruzi and human T cell lymphotropic virus type II (HTLV-II) in 658 people inhabiting the five main zones of the study area in Paraguay*
 
The results in Table 2Go also show that there were no significant differences in the overall T. cruzi seroprevalence between Chulupi rural communities (118 of 195, 60.5%) and the Chulupi communities located at the periphery of Filadelfia (34 of 61, 55.7%). The same was true of the differences in the overall HTLV-II prevalence between these communities (31.1% versus 33.3%). Likewise, the overall frequencies of T. cruzi and HTLV-II (33.6% and 11.8%, respectively) in the rural Lengua communities did not differ significantly from those (33.3% and 15.3%, respectively) of the Lengua communities located in the periphery of Filadelfia.

The distribution of T. cruzi and HTLV-II in Indians according to sex and age is shown in Table 3Go. After adjusting for age, sex, HTLV-II status, and hantavirus status, the overall seroprevalence of T. cruzi in males (49.4%) was significantly greater than that in females (40.5%) (OR = 1.61, 95% CI = 1.10–2.36). The overall T. cruzi seroprevalence almost doubled from the 13–17-year-old group (21.7%) to the 18–45-year-old group (42.6%) and increased markedly from this age group to the 46–80-year-old group (61.2%). As in the case of T. cruzi, the prevalence of HTLV-II increased with age in both sexes. However, the overall sex prevalence was the opposite of that of T. cruzi (OR = 0.46, 95% CI = 0.28–0.76 after adjusting for age, sex, T. cruzi status. and hantavirus status).


View this table:
[in this window]
[in a new window]
 
TABLE 3
Age and sex distribution of Trypanosoma cruzi and human T cell lymphotropic virus type II (HTLV-II) in Indians inhabiting the Paraguayan Gran Chaco*
 
In the group of 240 individuals whose family members were tested, having a T. cruzi seropositive member increased the chance of a subject being seropositive by 2.85 (95% CI = 1.57–5.18) after adjusting for age, sex, HTLV-II status, and hantavirus status.


DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The present finding of very high frequencies of T. cruzi seropositivity and HTLV-II infection in Indians inhabiting western Paraguay confirms and expands the results of our previous study conducted on a small number of subjects.9,10

The concurrence of high prevalence rates of both T. cruzi and HTLV-II in the same population offers an excellent opportunity to examine the associations between these infectious agents. In a previous study9 of 487 Indians inhabiting the northeastern part of the Salta province of Argentina, of which 209 were also examined for hantavirus, we did not find a statistically significant association between T. cruzi and HTLV-II after adjusting for age, sex, and hantavirus status. However, in the present study, which includes a much larger number of people examined for these agents we found, after adjusting for the same confounders, that a person infected with HTLV-II was 2.28 times more likely to be T. cruzi positive than an HTLV-II negative person.

Whatever its explanation, the finding that an individual infected with HTLV-II may have a significantly greater chance of being seropositive for T. cruzi may open new avenues for the search of yet unidentified risk factors for infections with these agents. The potential public health significance of this search is emphasized by the fact that in the Americas, approximately 18 million people are infected with T. cruzi, and the frequency of HTLV-II infection is on the increase.

Although the study of the reason(s) for the increased risk of T. cruzi infection in people infected with HTLV-II was beyond the scope of the present work, several possible explanations can be postulated on the basis of the information available in the literature. One possibility is that infection with HTLV-II impairs the immune system, thus rendering the host more susceptible to T. cruzi infection. The possibility that HTLV-II infection causes a mild immunosuppression has been proposed as an explanation for the association of HTLV-II with other infectious agents observed in blood donors and intravenous drug users.13–15

A T. cruzi-induced impairment of the immune system could be an alternative explanation for the observed association between this parasite and HTLV-II. Immunosuppression, manifested by altered T and B lymphocyte functions, has been shown to occur in people and laboratory animals acutely infected with T. cruzi.12 It is not known, however, whether the same is true in people chronically infected with the parasite. Other conceivable explanations for the association between T. cruzi and HTLV-II include the possibility that infections with these agents shared a yet unidentified common risk factor(s), and that HTLV-II-infected peripheral blood leukocytes are also transmitted by triatoma bugs.

The finding that T. cruzi seroprevalence is very high in the Indians (43.5%) and low (2.5%) in the non-Indians (Mennonites and Paraguayans) examined in western Paraguay is readily attributable to the distinct differences in exposure of these populations to the known risk factors for T. cruzi. Indeed, unlike the houses of the Mennonites and Paraguayans, the Indian dwellings had cracked or unplastered walls and thatched roofs with crevices that may provide ideal refugia for the triatomine vector. These construction features have been recognized as one of the main risk factors for T. cruzi infection.6–8 Also, the frequent presence of dogs, the main domestic reservoir of T. cruzi, in the sleeping areas and a high number of residents in the dwelling, which are also among the main known risk factors for T. cruzi infection,7,8 were typical of living conditions of the Indians, but not of the non-Indians studied.

The characteristics of the dwellings, the presence of dogs in the sleeping areas, and the number of household residents were similar for the Indians residing in the countryside and in the immediate periphery of Filadelfia. Thus, it is not surprising that the Indians living in these two settings had virtually the same frequency of T. cruzi seropositivity.

The seroprevalence of T. cruzi varied among the Indian groups. Communities of Chulupi and Lengua, which accounted for more than 80% of the Indian population examined, co-existed both in the periphery of Filadelfia and in the countryside of Yalve Sanga, and were close to each other. Even though there were no apparent differences among these communities regarding the characteristic of the dwellings, the presence of dogs in the sleeping areas, number of household residents, and activities of their members, in both settings seroprevalence was significantly greater in the Chulupi communities than in the Lengua communities. It is unlikely that this is due to differences in the application of vector control measures. According to information provided to us by residents, community heads and health workers, antitriatomine spraying was applied to only very few dwellings and only once. Further evidence that the spraying were either not conducted or were ineffective is the observation that in communities examined with an interval of four and a half years was that T. cruzi seroprevalence increased significantly or remained at the same level. Thus, it appears that the greater T. cruzi seroprevalence in Chulupi communities compared with Lengua communities was not due to differences in either exposure to known main risk factors, application of antitriatomide measures, or locations/settings of the communities. On the other hand, the observation that the differences in T. cruzi seroprevalence among the Chulupi and Lenguan communities were paralleled by differences in the prevalence of HTLV-II infection is consistent with the hypothesis that this virus infection constituted a risk factor for T. cruzi infection, or vice versa, or that these infections shared a common risk factor.

A cumulative exposure to the parasite is the most likely explanation for the age-associated increase in T. cruzi seropositivity observed in the Indians. A similar increase was also seen in our previous study9 and in another study.7 For the reasons discussed earlier, it seems unlikely that the observed increase in seroprevalence resulted from a lower exposure in the younger Indians resulting from anti-triatomine campaigns.

Our data show that after adjusting for age, T. cruzi seroprevalence was significantly greater in Indian males compared with Indian females. The same sex difference was observed in our previous study,9 although it was not statistically significant. The explanation for this sex difference is not apparent on the basis of the known domestic and peridomestic risk factors for T. cruzi infection. However, it is conceivable that, while males and females were equally exposed to domiciliary triatomines, some Indian males become infected as a result of exposure to sylvatic triatomines while sleeping in the open during hunting and gathering trips.

The observation that having a T. cruzi-seropositive family member increased the adjusted odds of an individual being seropositive, is consistent with previous data showing that in people inhabiting the Gran Chaco territory9 and other regions,1,2 infection with the parasite typically occurs in household clusters.

The findings that the prevalence of HTLV-II infection increases after puberty and is greater in females than in males confirm previous observations10 and are consistent with the view that in this population the virus is transmitted mainly from male to female via sexual intercourse.

In summary, our study reports the first observation of a strong association between T. cruzi and HTLV-II infections. This observation may provide important leads for studies aimed at the identification of new risk factors for these infections. Such studies may also contribute significantly to the understanding of the biologic properties and epidemiology of both T. cruzi and HTLV-II. The information on the association between these agents and our present data on the main parameters of the distribution of T. cruzi may also contribute to the control and prevention of Chagas’ disease.


Received February 14, 2002. Accepted for publication June 20, 2002.

Acknowledgments: We thank Dr. Andres Vidovich Morales (Ministro de Salud Pública y Bienestar Social of Paraguay) and Dr. Alvin Stahl (Director Médico del Hospital Filadelfia of Paraguay) for their invaluable support and contributions to our studies. We also thank Dr. Stahl for providing us with laboratory space in the Hospital Filadelfia and for facilitating our access to the people studied. The assistance of the personnel of this hospital and of the local health clinics is also gratefully acknowledged.

Financial support: This study was supported in part by a grant from the University of Pennsylvania Research Foundation and the Barbara Kopp Cancer Research Fund.

Authors’ addresses: Jorge F. Ferrer and David Galligan, New Bolton Center, University of Pennsylvania, 382 West Street Road, Kennett Square, PA 19348, Telephone: 610-444-5800, Fax: 610-925-8123. Eduardo Esteban, Alicia Murua, Silvina Gutierrez, and Leonardo Feldman, Area de Virología, Universidad Nacional del Centro de la Provincia de Buenos Aires, Pinto 399, 7000 Tandil, Argentina, Telephone/Fax: 54-2293-441912. Syamalima Dube and Bernard J. Poiesz, Department of Medicine, Hematology/Oncology Laboratories, State University of New York, 750 East Adams Street, Syracuse, NY 13210, Telephone: 315-464-5446, Fax: 315-464-8255. Miguel A. Basombrio, Laboratorio de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Buenos Aires 177, 4000 Salta, Argentina, Telephone/Fax : 54-87-255333.

Reprint requests: Jorge F. Ferrer, New Bolton Center, University of Pennsylvania, 382 West Street Road, Kennett Square, PA 19348, e-mail: jfferrer{at}vet.upenn.edu.


REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIAL AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. World Health Organization Expert Committee, 1991. Control of Chagas Disease. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 811: 1–95.[Medline]
  2. Storino R, Barragan H, 1994. Epidemiologia. Storino R, Milei J, eds. Enfermedad de Chagas. Madrid: Mosby-Doyma Press, 51–74.
  3. Gorla DE, Schofield CJ, 1989. Population dynamics of Triatoma infestans under natural climatic conditions in the Argentine Chaco. Med Vet Entomol 3: 179–194.[Medline]
  4. Kirchhoff L, Gam A, Gilliam F, 1987. American trypanosomiasis (Chagas’ disease) in Central American immigrants. Am J Med 82: 915–920.[Web of Science][Medline]
  5. Schmuñis GA, 1991. Trypanosoma cruzi, the etiological agent of Chagas’ disease: status in the blood supply in endemic and non-endemic countries. Transfusion 31: 547–557.[Web of Science][Medline]
  6. Mott KE, Miniz TM, Lehman JS Jr, Hoff R, Morrow RH, Oliveira TS, Sherlock IA, Draper CC, 1978. House construction, triatomine distribution and household distribution of seroreactivity to Trypanosoma cruzi in a rural community in northeast Brazil. Am J Trop Med Hyg 27: 1116–1122.
  7. Gürtler RE, Chuit R, Cécere MC, Castañera MB, Cohen JE, Segura EL, 1998. Household prevalence of seropositivity for Trypanosoma cruzi in three rural villages in northwest Argentina: environmental, demographic, and entomologic associations. Am J Trop Med Hyg 59: 741–749.[Abstract]
  8. Gürtler RE, Cohen JE, Cécere MC, Lauricella MA, Chuit R, Segura EL, 1998. Influence of humans and domestic animals in the household prevalence of Trypanosoma cruzi in Triatoma infestans populations in northwest Argentina. Am J Trop Med Hyg 58: 748–758.[Abstract]
  9. Basombrio MA, Segovia A, Peralta-Ramos M, Esteban E, Stumpf R, Jurgensen RP, Winkler MA, Sayre K, Ferrer JF, 1999. Endemic Trypanozoma cruzi infection in Indian populations of the Gran Chaco territory of South America. Ann Trop Med Parasitol 93: 41–48.[Medline]
  10. Ferrer JF, Esteban E, Dube S, Basombrio MA, Segovia A, Peralta-Ramos M, Dube D K, Sayre K, Aguayo N, Hengst J, Poiesz BJ, 1996. Endemic infection with the human T lymphotropic virus type IIB in Argentinean and Paraguayan Indians: epidemiology and molecular characterization. J Infect Dis 174: 944–953.[Web of Science][Medline]
  11. Ferrer JF, Jonsson CB, Esteban E, Galligan D, Basombrio MA, Peralta-Ramos M, Bharadwaj M, Torrez-Martinez N, Callahan J, Segovia A, Hjelle B, 1998. High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco. Am J Trop Med Hyg 58: 438–444.
  12. Kierszenbaum F, Sztein MB, 1994. Chagas’ disease (American trypanosomiasis). Kierszenbaum F, ed. Parasitic Infections and the Immune System. San Diego, CA: Academic Press, 53–85.
  13. Murphy EL, Glynn SA, Fridey J, Smith JW, Sacher RA, Nass CC, Ownby HE, Wright DJ, Nemo GJ, 1999. Increased incidence of infectious disease during prospective follow-up of human lymphotropic virus type-II-and I-infected blood donors. Arch Intern Med 159: 1485–1491.[Abstract/Free Full Text]
  14. Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, Newman B, Gibble JW, Ameti DI, Nass CC, Schreiber GB, Nemo GJ, 1997. Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus type I-and II-infected blood donors. J Infect Dis 176: 1468–1475.[Web of Science][Medline]
  15. Modahl LE, Young KC, Varney KF, Khayam-Bashi H, Murphy EL, 1997. Injection drug users seropositive for HTLV-II are at increased risk for pneumonia, abscess and lymphoadenopathy. J Acquir Immune Defic Syndr Hum Retrovirol 16: 169–175.[Web of Science][Medline]
  16. Gonzalez LM, Lindsey AE, Hjelle B, Dominguez D, Brown J, Jonsson CB, 2001. Prevalence of antibodies to Sin Nombre virus in humans living in rural areas of southern New Mexico and western Texas. Virus Res 74: 177–179.[Medline]
  17. Allison P, 1999. Logistic Regression Using the SAS System: Theory and Application. Cary NC: SAS Institute, Inc., 31–78.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FERRER, J. F.
Right arrow Articles by GALLIGAN, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FERRER, J. F.
Right arrow Articles by GALLIGAN, D.
Related Collections
Right arrow Trypanosomiasis
Right arrow Chagas Disease
Right arrow Epidemiology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS